{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreic24tkejpojsgn23shhnd6lmi7vgo4e7v32r4oqnbgyktwo7gnngu",
    "uri": "at://did:plc:2gbt2dlwaqovtnmxkat3tyke/app.bsky.feed.post/3mlfksenddvo2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreih4q3eghpsyfjjtp44isdhiaflrvwq7adxo7fonikxylej6bg3kji"
    },
    "mimeType": "image/jpeg",
    "size": 128554
  },
  "path": "/articles/d41586-026-01447-2",
  "publishedAt": "2026-05-09T05:57:35.254Z",
  "site": "https://www.nature.com",
  "tags": [
    "doi:10.1038/d41586-026-01447-2"
  ],
  "textContent": "Nature, Published online: 08 May 2026; doi:10.1038/d41586-026-01447-2\n\nPeople with a deadly form of pancreatic cancer survive longer on a drug that blocks the activity of a family of mutant proteins.",
  "title": "‘Undruggable’ cancer proteins meet their match",
  "updatedAt": "2026-05-08T00:00:00.000Z"
}